Zephyrnet Logo

Tag: digital therapeutics

Top News

Bridging Medical Device Hardware & Software with BLE

MedTech makes use of advanced Bluetooth Low Energy (BLE) features in our Bluetooth-enabled medical devices, ones that require specialized technical knowledge to get right....

Crucial Data Solutions Announces Industry-First Web & Mobile eClinical Platform with Enterprise Subscription Pricing – Crucial Data Solutions

RENO, Nev.–(BUSINESS WIRE)–Crucial Data Solutions (CDS), the only SaaS platform to empower customer-driven global clinical trials for web and mobile environments, announced today the...

MedRhythms Announces FDA Listing of InTandem™ (MR-001) to Improve Walking and Ambulation in Adults with Chronic Stroke | BioSpace

  Stroke is a leading cause of long-term disability, and over half of people aged 65 or older who have had a stroke...

Solving Edge Cases for BLE Medical Devices: Webinar

Bluetooth Low Energy (BLE) may be a convenient communication protocol, but dropping it into a connected medical device isn’t nearly as easy. Depending on...

The Summit Forum on the Application and Construction of AGP in China Takes Place in Shenzhen | BioSpace

SHENZHEN, China, June 19, 2023 /PRNewswire/ -- On June 9, the Summit Forum on the Application and Construction of AGP in China, led by...

Digital health tech: a solution to substance use disorders?

<!----> Healthcare providers are under pressure to address the growing issue of substance use disorders. Spurred on by...

Tapping into digital therapeutics to improve neurological outcomes

<!----> As the field of digital therapeutics continues to broaden, specific uses in mental health and neurology are...

[Theranica in PR Newswire] Theranica enters into agreement with Dr. Reddy’s for commercializing Nerivio® in India

NETANYA, Israel, Jan. 10, 2023 /PRNewswire/ — Theranica, a prescribed digital therapeutics company developing advanced neuromodulation devices for migraine and other pain conditions, today...

New opportunity: DayTwo – 2023-01-06

Funding data <!-- --> Details Country Israel...

Wellbeing Subsidiary KGK Science Receives Approval for First-of-its-Kind Psylocibin Clinical Trial

KGK has received approval from Health Canada for Phase II clinical trial to test the efficacy of psilocybin on Fragile X syndrome VANCOUVER, British Columbia–(BUSINESS...

How advancing tech has shaped mental health in 2022

<!----> The mental health landscape has welcomed discoveries, launches and experiences that showcase immersive technologies. Research, innovations and...

Consumer Health: Areas of Opportunity

In a market full of bears, we are bulls when it comes to consumer health companies. In our last piece, we made the bold...

Latest Intelligence

spot_img
spot_img

Chat with us

Hi there! How can I help you?